• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Investigation of mechanisms to keep blood vessels patent in hepatocellular carcinoma.

Research Project

Project/Area Number 24590499
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Experimental pathology
Research InstitutionKanagawa Cancer Center Research Institute

Principal Investigator

MIYAGI Yohei  地方独立行政法人神奈川県立病院機構神奈川県立がんセンター(臨床研究所), その他部局等, 総括部長 (00254194)

Co-Investigator(Kenkyū-buntansha) KOIZUME Shiro  神奈川県立がんセンター臨床研究所, 主任研究員 (60416063)
Project Period (FY) 2012-04-01 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2014: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2013: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Keywords凝固第VII因子 / 組織因子 / 凝固 / 肝がん / TFPI / TF / fVII / 肝細胞癌 / 血栓塞栓 / tissue factor / 血液凝固第7因子 / 血液凝固
Outline of Final Research Achievements

Hepatocellular carcinoma (HCC) cells produce both blood coagulation factor-VII (fVII) and tissue factor (TF). We clarified in the present study that under such circumstances, HCC cells do not elicit TF-fVIIa blood coagulation pathway because of ectopic tissue factor pathway inhibitor (TFPI)-1 production. At least in HCC cells, there exist a mechanism to keep patency of tumor vessels, that could be a good target for novel anticancer therapy.

Report

(4 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report
  • 2012 Research-status Report
  • Research Products

    (4 results)

All 2014 2012 Other

All Journal Article (3 results) (of which Peer Reviewed: 3 results,  Open Access: 2 results) Presentation (1 results)

  • [Journal Article] Breast cancer phenotypes regulated by tissue factor-factor VII pathway: Possible therapeutic targets.2014

    • Author(s)
      Koizume, S and Miyagi, Y.
    • Journal Title

      World J Clin Oncology

      Volume: 5(5) Issue: 5 Pages: 908-920

    • DOI

      10.5306/wjco.v5.i5.908

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Angiomodulin (AGM/IGFBP-rP1) is a molecular marker of vascular endothelial cells activated by VEGF in human breast cancers.2014

    • Author(s)
      Komiya, E, Sato, H., Ise, I., Watanabe, N., Higashi, H., Miyagi, Y., Miyazaki, K.
    • Journal Title

      Cancer Med

      Volume: 印刷中 Issue: 3 Pages: 537-549

    • DOI

      10.1002/cam4.216

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] HIF2α-Sp1 interaction mediates a deacetylation-dependent FVII-gene activation under hypoxic conditions in ovarian cancer cells2012

    • Author(s)
      Koizume S, Ito S, Miyagi E, Hirahara F, Nakamura Y, Sakuma Y, Osaka H, Takano Y, Ruf W, Miyagi Y
    • Journal Title

      Nucleic Acid Research

      Volume: 40(12) Issue: 12 Pages: 5389-5401

    • DOI

      10.1093/nar/gks201

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Presentation] 肝細胞癌で発見する異所性TFPI1による癌細胞での接着阻害

    • Author(s)
      伊藤 慎,小井詰史朗、高野康雄、宮城洋平
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      札幌
    • Related Report
      2012 Research-status Report

URL: 

Published: 2013-05-31   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi